Yseop

Generative AI is reshaping clinical documentation and regulatory submissions, offering faster, more efficient processes. However, its true success lies in addressing critical challenges: data readiness, optimizing content ecosystems, and eliminating inefficiencies in CSR creation. vanessa de langsdorff of Yseop recently collaborated with John April of Eli Lilly and Company and Inger Ødum Nielsen of Novo Nordisk to publish an article in Applied Clinical Trials Magazine, exploring how organizations are overcoming these challenges and maximizing the return on GenAI investments. 📖 Read the full piece here: https://lnkd.in/eD8i4QiG #GenerativeAI #MedicalWriting #RegulatoryAffairs

At Yseop, we’re at the forefront of this revolution, helping life sciences organizations automate, accelerate, and optimize medical writing with AI-driven solutions. From task automation and instant document drafting to streamlined collaboration and regulatory compliance, AI is redefining how medical teams work—boosting efficiency while ensuring accuracy. Our CEO, Emmanuel Walckenaer, explores these benefits in detail, highlighting how AI is not just a tool, but a strategic advantage in pharma and healthcare. 📖 Read the full article: https://ow.ly/Iugv50UOtIq #MedicalWriting #AI #Pharma #Innovation #Collaboration

Emmanuel Walckenaer, CEO of Yseop, returns to AI Uncovered to discuss AI’s impact on regulatory submissions, clinical workflows and medical writing as adoption accelerates in 2025. He and Tim Martin explore 2024’s biggest breakthroughs, the role of automation and key priorities for a successful future. A must-listen! Tune in now: 👉Yseop page: https://bit.ly/4b5Jckp 👉Youtube: https://bit.ly/4hIwNFC 👉Soundcloud: https://bit.ly/41pjXGD 👉 Amazon: https://bit.ly/3D2z6Ed 👉 Spotify: https://bit.ly/41pflQL 👉 Apple: https://bit.ly/43618JO #AI #Automation #TechPodcast #LLM #GenerativeAI #ChatGPT #Pharma #Biopharma #ArtificialIntelligence #LifeSciences #MedicalWriting #RegulatoryAffairs #Biotech #ClinicalTrials #Regulatory #AIUncovered #AIinPharma #PharmaInnovation #genai

DIA Europe 2025 is one month away! Join us in Basel, Switzerland, from March 18–20 at Booth #F4 and don’t miss Emmanuel Walckenaer, CEO of Yseop, Innovation Theater session on March 18 at 10:05 AM CET. We’ll explore how Generative AI is transforming medical writing—increasing efficiency, improving quality and accelerating regulatory and clinical workflows. Want to connect? Request a meeting, and our team will be in touch: https://bit.ly/3EFqnbr #DIAEurope2025 #GenAI #MedicalWriting #Biopharma #AIInnovation #Yseop Thomas ALBY Clarisse dos Santos, PhD Maxime Dufresne DIA

AI adoption is accelerating—five European businesses adopt AI every minute. Yet, as Amazon Web Services (AWS) Tanuja Randery pointed out on CNBC International, a two-tier AI economy is emerging. While some organizations are rapidly integrating AI to drive innovation, others face barriers such as skills gaps, regulatory uncertainty, and cost concerns. In this conversation, Yseop was featured as a key player in the startup space, recognized for using AI to transform complex medical data into regulatory documents—cutting processes from months to seconds and accelerating time to market for new therapies. As AI reshapes industries, we’re proud to be at the forefront, helping organizations streamline processes, enhance compliance, and drive efficiency. #AI #Automation #LifeSciences #CNBC #TechInnovation

Chez Yseop, notre mission est d’accélérer l’approbation des médicaments grâce à l’IA, en réduisant drastiquement le temps nécessaire à la génération de documents réglementaires critiques – passant de plusieurs heures à quelques secondes. À la clé ? Un accès plus rapide et à grande échelle à des traitements vitaux. Nous sommes fiers d’être mis en avant dans le tout premier AWS Pioneers Project, qui illustre comment notre utilisation de l’IA générative avec Amazon Web Services (AWS) contribue à accélérer la mise à disposition de nouveaux médicaments pour les patients. Découvrez le projet: https://bit.ly/4gHxyxb #AWS #GenerativeAI #MedicalInnovation #DrugDevelopment #AWSPioneers #Innovation #IAGenerative #TechForGood

Yseop's mission is to accelerate drug approvals with AI, reducing the time needed to generate critical regulatory documents from hours to seconds. The result? Faster access to life-saving treatments at scale. We're proud to be featured in the inaugural AWS Pioneers Project, highlighting how our use of Generative AI with Amazon Web Services (AWS) is helping bring new medicines to patients faster. Learn more: bit.ly/42SPMsh #AWS #GenerativeAI #MedicalInnovation #DrugDevelopment #AWSPioneers #Innovation #GenAI #TechForGood

Join Yseop at DIA Europe 2025 in Basel, Switzerland from March 18–20 at Booth #F4. Discover how Generative AI is transforming medical writing and helping biopharma companies enhance efficiency and quality in drug development workflows. Catch our Innovation Theater session on Tuesday, March 18 at 10:05 AM CET in the Innovation Hub, where we’ll discuss the role of Generative AI in medical writing amid the surge in new drug development. Want to connect? Request a meeting, and a Yseop representative will be in touch to schedule a time that works for you: https://bit.ly/4hZqYU1 #DIAEurope2025 #GenAI #MedicalWriting #Biopharma #DIA #DrugDevelopment #RegulatoryAffairs Clarisse dos Santos, PhD Thomas ALBY Maxime Dufresne

Not all AI agents are created equal. Some follow predefined workflows, executing static tasks within rigid structures. Others, however, are dynamic—capable of reasoning, adapting and orchestrating complex processes autonomously.    At Yseop, we’re pushing the boundaries of agentic workflows, moving beyond traditional LLM-powered automations to intelligent agents that can plan, act and improve over time. This shift is game-changing for biopharma.    🔹 From static LLM workflows to dynamic AI agents  🔹 From rule-based orchestration to intelligent decision-making  🔹 From fragmented automation to seamless, scalable systems With new funding secured, at Yseop, we're accelerating platform enhancements to build more precise, compliant and scalable content automation solutions—unlocking a new era of AI-driven transformation in biopharma. Want to dive deeper? Read our latest blog post: https://bit.ly/4hOA2vj #AI #LLM #automation #biopharma #innovation #aiagents

Tim Martin, EVP of Product and Development at Yseop, is featured in Tech Brew’s latest article on the current state and future of AI. He shares how Yseop is leveraging retrieval-augmented generation (#RAG) and AI agents to refine foundation models for scientific language generation. While some AI giants hit a wall with diminishing returns, Yseop proves that specialized, purpose-built AI solutions are driving real impact. The future of AI isn’t about scaling bigger models—it’s about smarter, more adaptable solutions. See how Yseop is leading the way. Read the full article here: https://bit.ly/3QeOUXz #opendata #clinicalresearch #artificialintelligence #AI #innovation